Pilar Casas-Llera
Research Subjects
Pilar Casas-Llera has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
D. Ruiz-Casas
Departamento de Oftalmología. Hospital Ramón y Cajal, Madrid, España
2 shared publicationsJ.L. Alió
Unidad de Córnea, Cataratas y Cirugía Refractiva de Vissum (Grupo Miranza), Alicante, España; Departamento de Oftalmología, Patología y Cirugía, Universidad Miguel Hernández, Alicante, España
2 shared publicationsF J Munoz-Negrete
1 shared publication- Francisco Arnalich-Montiel
Department of Ophthalmology, Hospital Universitario Ramon y Cajal, Madrid, Spain
1 shared publication Francisco J. Muñoz-Negrete
Hospital Ramon y Cajal, Madrid, Spain
1 shared publicationG Rebolleda
1 shared publication
Latest Publications
- Open Access
- 18 April 2026
- Published by Press of International Journal of Ophthalmology (IJO Press) in International Journal of Ophthalmology
- Vol. 19 (4) , 701-708
Efficacy and safety of the VISULAS green with option selective laser trabeculoplasty in pseudoexfoliative syndrome glaucoma and pseudoexfoliative syndrome ocular hypertension
AIM: To assess the effectiveness and safety of VISULAS® green laser selective laser trabeculoplasty (SLT) in lowering intraocular pressure (IOP) in patients with pseudoexfoliative syndrome glaucoma (PEXG) and pseudoexfoliative syndrome ocular hypertension (PEXS-OHT). METHODS: This prospective, single-center, interventional study included 20 eyes from 20 patients diagnosed with PEXG or PEXS-OHT. Patients underwent 180° SLT using the VISULAS® green laser, a diode-pumped, frequency-doubled Nd:YVO4 laser with a 532 nm wavelength. IOP was measured at baseline and post-treatment at 1, 3, and 6mo. Medications regimen was stable through the study. Primary outcomes included mean IOP reduction, while secondary outcomes assessed visual and structural parameters, and safety. RESULTS: The mean age of participants was 72.2±6.6y, with 65% of the eyes being left eyes and 35% right eyes. At baseline, the mean IOP was 22.9±2.9 mm Hg. A significant reduction in IOP was observed at all follow-up intervals: 18.5±3.1 mm Hg at 1mo (18.8% reduction, P=0.001), 19.0±4.2 mm Hg at 3mo (16.7% reduction, P=0.002), and 18.2±4.5 mm Hg at 6mo (19.8% reduction, P=0.001). Subgroup analysis showed greater IOP reduction in patients with Shaffer grade 4 angles, phakic eyes, and those with PEXS-OHT compared to PEXG. No significant changes were detected in visual acuity, visual field index, mean deviation, or retinal nerve fiber layer thickness. At 1h post-procedure, 20% of eyes showed an IOP spike >5 mm Hg that resolved without intervention except for one patient. CONCLUSION: SLT with the VISULAS® green laser is an effective and safe treatment for PEXG and PEXS-OHT, achieving significant IOP reduction without increasing medication burden or causing severe complications. These findings suggest its potential as an alternative or adjunct therapy in managing pseudoexfoliative glaucoma.
- 18 April 2026
- Published by Press of International Journal of Ophthalmology (IJO Press) in International Journal of Ophthalmology
- Vol. 19 (4) , 701-708
Open AccessEfficacy and safety of the VISULAS green with option selective laser trabeculoplasty in pseudoexfoliative syndrome glaucoma and pseudoexfoliative syndrome ocular hypertension
AIM: To assess the effectiveness and safety of VISULAS® green laser selective laser trabeculoplasty (SLT) in lowering intraocular pressure (IOP) in patients with pseudoexfoliative syndrome glaucoma (PEXG) and pseudoexfoliative syndrome ocular hypertension (PEXS-OHT). METHODS: This prospective, single-center, interventional study included 20 eyes from 20 patients diagnosed with PEXG or PEXS-OHT. Patients underwent 180° SLT using the VISULAS® green laser, a diode-pumped, frequency-doubled Nd:YVO4 laser with a 532 nm wavelength. IOP was measured at baseline and post-treatment at 1, 3, and 6mo. Medications regimen was stable through the study. Primary outcomes included mean IOP reduction, while secondary outcomes assessed visual and structural parameters, and safety. RESULTS: The mean age of participants was 72.2±6.6y, with 65% of the eyes being left eyes and 35% right eyes. At baseline, the mean IOP was 22.9±2.9 mm Hg. A significant reduction in IOP was observed at all follow-up intervals: 18.5±3.1 mm Hg at 1mo (18.8% reduction, P=0.001), 19.0±4.2 mm Hg at 3mo (16.7% reduction, P=0.002), and 18.2±4.5 mm Hg at 6mo (19.8% reduction, P=0.001). Subgroup analysis showed greater IOP reduction in patients with Shaffer grade 4 angles, phakic eyes, and those with PEXS-OHT compared to PEXG. No significant changes were detected in visual acuity, visual field index, mean deviation, or retinal nerve fiber layer thickness. At 1h post-procedure, 20% of eyes showed an IOP spike >5 mm Hg that resolved without intervention except for one patient. CONCLUSION: SLT with the VISULAS® green laser is an effective and safe treatment for PEXG and PEXS-OHT, achieving significant IOP reduction without increasing medication burden or causing severe complications. These findings suggest its potential as an alternative or adjunct therapy in managing pseudoexfoliative glaucoma.
- 1 November 2021
- Published by Elsevier in Archivos de la Sociedad Española de Oftalmología (English Edition)
- Vol. 96, 60-67
Macular involvement in congenital aniridia
- 1 November 2021
- Published by Elsevier in Archivos de la Sociedad Española de Oftalmología (English Edition)
- Vol. 96, 60-67
Macular involvement in congenital aniridia
- 1 November 2021
- Published by Elsevier in Archivos de la Sociedad Española de Oftalmología
- Vol. 96, 60-67
Alteraciones maculares en aniridia congénita
- 1 November 2021
- Published by Elsevier in Archivos de la Sociedad Española de Oftalmología
- Vol. 96, 60-67
Alteraciones maculares en aniridia congénita
- 1 September 2011
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 37 (9) , 1729-1731
Retinal imaging after corneal inlay implantation
We report 2 cases of implantation with the Kamra corneal inlay to describe central and peripheral retinal visibility and the quality of optical coherence tomography (OCT) scans. Under pharmacological mydriasis, the central and peripheral retina was explored without disturbance by an experienced retinal ophthalmologist. Central color imaging was done without difficulty, and peripheral imaging was accurate despite a small bright shadow in every image. The quality of the OCT scans of the macular line, macular 3-dimensional cube, and macular radial protocols were 156.51, 77.49, and 84.35, respectively, in patient 1 and 106.66, 63.03, and 64.69, respectively, in patient 2 without artifact scanning. The inlay allowed normal visualization of the central and peripheral fundus, as well as good-quality central and peripheral imaging and OCT scans.
- 1 September 2011
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 37 (9) , 1729-1731
Retinal imaging after corneal inlay implantation
We report 2 cases of implantation with the Kamra corneal inlay to describe central and peripheral retinal visibility and the quality of optical coherence tomography (OCT) scans. Under pharmacological mydriasis, the central and peripheral retina was explored without disturbance by an experienced retinal ophthalmologist. Central color imaging was done without difficulty, and peripheral imaging was accurate despite a small bright shadow in every image. The quality of the OCT scans of the macular line, macular 3-dimensional cube, and macular radial protocols were 156.51, 77.49, and 84.35, respectively, in patient 1 and 106.66, 63.03, and 64.69, respectively, in patient 2 without artifact scanning. The inlay allowed normal visualization of the central and peripheral fundus, as well as good-quality central and peripheral imaging and OCT scans.
- 16 June 2009
- Published by BMJ in British Journal of Ophthalmology
- Vol. 93 (12) , 1576-1579
Visual field index rate and event-based glaucoma progression analysis: comparison in a glaucoma population
Aims: The aim of the study was to compare event-based glaucoma progression analysis (GPA) I with new GPA II software and pattern deviation-based trend analyses (visual field index [VFI]) to detect progression in a glaucoma population. Methods: This was a retrospective study that included 90 eyes of 90 patients with a minimum of five reliable visual field tests and a follow-up period of at least 2 years. Results: Event-based GPA II detected progression in 16.7% of eyes in which trend analysis VFI failed. GPA detected progression 6.8 months earlier than VFI. GPA I and II showed excellent agreement (k = 0.94). Agreement between VFI and mean deviation (MD) linear analysis and with GPA criteria was k = 0.52 and k = 0.48, respectively. Mean rates of progression of MD and VFI were −0.41 dB and −1.30% annually, respectively (rho = 0.824; pConclusions: Event-based software GPA I and II had excellent agreement. Event analysis showed earlier and greater sensitivity for detecting progression than VFI analysis and both had only moderate agreement. Trend analysis VFI is likely to detect progression in patients with a greater number of visual field tests and a longer follow-up time. The VFI analysis seems to be more accurate than MD analysis for determining rate of progression.
- 16 June 2009
- Published by BMJ in British Journal of Ophthalmology
- Vol. 93 (12) , 1576-1579
Visual field index rate and event-based glaucoma progression analysis: comparison in a glaucoma population
Aims: The aim of the study was to compare event-based glaucoma progression analysis (GPA) I with new GPA II software and pattern deviation-based trend analyses (visual field index [VFI]) to detect progression in a glaucoma population. Methods: This was a retrospective study that included 90 eyes of 90 patients with a minimum of five reliable visual field tests and a follow-up period of at least 2 years. Results: Event-based GPA II detected progression in 16.7% of eyes in which trend analysis VFI failed. GPA detected progression 6.8 months earlier than VFI. GPA I and II showed excellent agreement (k = 0.94). Agreement between VFI and mean deviation (MD) linear analysis and with GPA criteria was k = 0.52 and k = 0.48, respectively. Mean rates of progression of MD and VFI were −0.41 dB and −1.30% annually, respectively (rho = 0.824; pConclusions: Event-based software GPA I and II had excellent agreement. Event analysis showed earlier and greater sensitivity for detecting progression than VFI analysis and both had only moderate agreement. Trend analysis VFI is likely to detect progression in patients with a greater number of visual field tests and a longer follow-up time. The VFI analysis seems to be more accurate than MD analysis for determining rate of progression.